MEDI-QUALITE OMEGA

MEDI-QUALITE OMEGA provides tailored strategic consulting services for pharma and biotech companies, with a Global and European focus. We specialize in: • Early engagement (trade off assessment & study designs, as early as POC studies) • Health Technology Assessment (HTA) • Market access, Pricing and Reimbursement (P&R) Our Comparative Advantage lies in our in-house transversal expertise from a pharma, clinical, public health, basic science, and a payer perspective, with diverse geographic origins. The team is supported by our network of international HTA experts and decision-makers. We guarantee state-of-the-art analysis on Patient Access research, benchmarks, challenges, and trends. We work throughout the development phase of a product up to the negotiation with payers, with a special focus on disruptive innovations (eg. in orphan diseases, oncology).